UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Journal of thrombosis and haemostasis, 2006-02, Vol.4 (2), p.295-306

2006

Volltextzugriff (PDF)

Fluvastatin inhibits up‐regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells

Journal of thrombosis and haemostasis, 2004-09, Vol.2 (9), p.1558-1563

2004

Volltextzugriff (PDF)

EULAR recommendations for the management of antiphospholipid syndrome in adults

Annals of the rheumatic diseases, 2019-10, Vol.78 (10), p.1296-1304

2019

Volltextzugriff (PDF)

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

Annals of the rheumatic diseases, 2017-03, Vol.76 (3), p.476-485

2017

Volltextzugriff (PDF)

‘Criteria’ aPL tests: Report of a Task Force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010

Lupus, 2011-02, Vol.20 (2), p.182-190

2011

Volltextzugriff (PDF)

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Nature reviews. Rheumatology, 2011-06, Vol.7 (6), p.330-339

2011

Volltextzugriff (PDF)

Endothelial Activation by aPL: A Potential Pathogenetic Mechanism for the Clinical Manifestations of the Syndrome

Journal of Autoimmunity, 2000-09, Vol.15 (2), p.237-240

2000

Volltextzugriff (PDF)

Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial—comment on: ‘Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus’ by Chatzidionysiou et al

Annals of the rheumatic diseases, 2022-08, Vol.81 (8), p.e140-e140

2022

Volltextzugriff (PDF)

European consensus statement on the terminology used in the management of lupus glomerulonephritis

Lupus, 2009-03, Vol.18 (3), p.257-263

2009

Volltextzugriff (PDF)

Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies

Autoimmunity reviews, 2022-03, Vol.21 (3), p.103012-103012, Article 103012

2022

Volltextzugriff (PDF)

Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers

Arthritis research & therapy, 2014-01, Vol.16 (2), p.209-209

2014

Volltextzugriff (PDF)

Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome

Lupus, 2008-10, Vol.17 (10), p.938-943

2008

Volltextzugriff (PDF)

Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

Arthritis & rheumatology (Hoboken, N.J.), 2021-06, Vol.73 (6), p.1073-1085

2021

Volltextzugriff (PDF)

Accelerated atherosclerosis in autoimmune rheumatic diseases

Circulation (New York, N.Y.), 2005-11, Vol.112 (21), p.3337-3347

2005

Volltextzugriff (PDF)

Prevention of cardiovascular disease in rheumatoid arthritis

Autoimmunity reviews, 2015-10, Vol.14 (10), p.952-969

2015

Volltextzugriff (PDF)

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study

BJOG : an international journal of obstetrics and gynaecology, 2019-04, Vol.126 (5), p.656-661

2019

Volltextzugriff (PDF)

Infectious origin of the antiphospholipid syndrome

Annals of the rheumatic diseases, 2006-01, Vol.65 (1), p.2-6

2006

Volltextzugriff (PDF)

IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus

Seminars in immunology, 2019-08, Vol.44, p.101330-101330, Article 101330

2019

Volltextzugriff (PDF)

Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases

Journal of autoimmunity, 2020-12, Vol.115, p.102524-102524, Article 102524

2020

Volltextzugriff (PDF)

Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study

Thrombosis and haemostasis, 2014, Vol.112 (4), p.727-735

2014

Volltextzugriff (PDF)

Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

PloS one, 2017-02, Vol.12 (2), p.e0169830-e0169830

2017

Volltextzugriff (PDF)

New oral anticoagulants in thrombotic antiphospholipid syndrome

Lupus, 2014-10, Vol.23 (12), p.1279-1282

2014

Volltextzugriff (PDF)

New strategies to address the pharmacodynamics and pharmacokinetics of tumor necrosis factor (TNF) inhibitors: A systematic analysis

Autoimmunity reviews, 2015-09, Vol.14 (9), p.812-829

2015

Volltextzugriff (PDF)

Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases

Autoimmunity reviews, 2023-03, Vol.22 (3), p.103259, Article 103259

2023

Volltextzugriff (PDF)

PReS13-SPK-1240: New aspects on APS pathogenesis

Pediatric rheumatology online journal, 2013-12, Vol.11 (S2), p.I11-I11, Article I11

Meroni, PL

2013

Volltextzugriff (PDF)

1 – 25 von 283

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(252)
Mit Volltextzugriff
(229)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(221)
Life Sciences & Biomedicine
(199)
Humans
(173)
Female
(103)
Immunology
(79)
Rheumatology
(78)
Biological And Medical Sciences
(76)
Male
(72)
Medical Sciences
(70)
Adult
(65)
Animals
(56)
Middle Aged
(46)
Pregnancy
(33)
Endothelium, Vascular - Immunology
(31)
Lupus Erythematosus, Systemic - Immunology
(29)
Thrombosis
(29)
Antiphospholipid Syndrome - Immunology
(27)
Mice
(26)
Antibodies
(25)
Antiphospholipid Antibodies
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Fluvastatin inhibits up‐regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells

EULAR recommendations for the management of antiphospholipid syndrome in adults

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

‘Criteria’ aPL tests: Report of a Task Force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Endothelial Activation by aPL: A Potential Pathogenetic Mechanism for the Clinical Manifestations of the Syndrome

European consensus statement on the terminology used in the management of lupus glomerulonephritis

Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies

Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers

Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome

Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

Accelerated atherosclerosis in autoimmune rheumatic diseases

Prevention of cardiovascular disease in rheumatoid arthritis

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study

Infectious origin of the antiphospholipid syndrome

IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus

Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases

Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study

Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

New oral anticoagulants in thrombotic antiphospholipid syndrome

New strategies to address the pharmacodynamics and pharmacokinetics of tumor necrosis factor (TNF) inhibitors: A systematic analysis

Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases

PReS13-SPK-1240: New aspects on APS pathogenesis

Aktive Filter

Suchergebnisse filtern